Chronic metabolic diseases with increasing prevalence and morbidity have posed serious challenges to the global healthcare ...

It will be driven by significant advancements in gastrointestinal disorders treatments. The global cell and gene therapy (CGT ...

1Department of Molecular and Systems Biology, Dartmouth Geisel School of Medicine, Lebanon, New Hampshire.

For patients with atrial fibrillation and obesity, lifestyle modification plus antiarrhythmic drug therapy conferred various ...

Patients who have acute myocardial infarction (AMI) complicated by cardiogenic shock (CS) experience elevated mortality rates ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...

Researchers conducted a retrospective study to evaluate the feasibility of LT4 and Liothyronine (LT3) combination therapy vs LT4 with placebo in individuals with post-surgical hypothyroidism. They ...

China NMPA grants breakthrough therapy designation for Innovent’s PD-1/IL-2a-bias bispecific antibody fusion protein, IBI363 in melanoma: San Francisco, US Tuesday, April 1, 202 ...

We’re so pleased he was able to have the gene therapy – it’s been incredible. We recently celebrated his first birthday.” ...